ImmunityBio (NASDAQ:IBRX) Given Buy Rating at HC Wainwright
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $8.00 target price on the stock. HC Wainwright’s target price would suggest a potential upside of 223.89% from the company’s current price. Other […]
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $8.00 target price on the stock. HC Wainwright’s target price would suggest a potential upside of 223.89% from the company’s current price. Other […]